Evidence map›Paper›PMID 19302917›Full record

ArticleExperimental hematology2009

Silencing of genes required for glycosylphosphatidylinositol anchor biosynthesis in Burkitt lymphoma.

Rong Hu, Galina L Mukhina, Soo Hee Lee, Richard J Jones, Paul T Englund, Patrick Brown, Saul J Sharkis, J Thomas Buckley, Robert A Brodsky

Open access · greenAbstract read
In one paragraph

Article in Experimental hematology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Paroxysmal nocturnal hemoglobinuria from bench to bedside.Clinical and translational science · 2011
    Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Rong HuDivision of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD 21205-2196, USA.
Galina L Mukhina
Soo Hee Lee
Richard J Jones
Paul T Englund
Patrick Brown
Saul J Sharkis
J Thomas Buckley
Robert A Brodsky
Johns Hopkins Medicine · USSidney Kimmel Comprehensive Cancer Center · USJohns Hopkins University · USUniversity of Victoria · CA

Funding

THERAPEUTIC USE OF STEM CELLSP01CA070970 · NCI · JOHNS HOPKINS UNIVERSITY · PI CIVIN, CURT I · 1998 to 2012
$23.7M
Treatment of lymphoma by death receptor induced apoptosisP50CA096888 · NCI · JOHNS HOPKINS UNIVERSITY · PI AMBINDER, RICHARD FREDERICK · 2002 to 2009
$13.6M
EXPERIMENTAL HEMATOPOIETIC STEM CELL GROWTHR01HL054330 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI SHARKIS, SAUL JOSEPH · 1996 to 2006
$3.1M
Trypansome Surface GlycoproteinsR01AI021334 · NIAID · JOHNS HOPKINS UNIVERSITY · PI ENGLUND, PAUL T · 1985 to 2006
$2.8M
Developing FLT3-Targeted Therapy for Pediatric LeukemiaK23CA111728 · NCI · JOHNS HOPKINS UNIVERSITY · PI BROWN, PATRICK A · 2006 to 2010
$701k
NCI NIH HHS CA70970NCI NIH HHS K23 CA111728NCI NIH HHS P01 CA070970NCI NIH HHS P50 CA096888NCI NIH HHS P50CA096888-01NHLBI NIH HHS HL54330NHLBI NIH HHS R01 HL054330NIAID NIH HHS AI21334NIAID NIH HHS R01 AI021334
6 · The paper itself

Abstract

objectiveTo investigate the mechanism of glycosylphosphatidylinositol (GPI) anchor deficiency in Burkitt lymphoma cell lines.

methodsWe identified a large GPI anchor protein deficient population in three different Burkitt lymphoma cell lines through proaerolysin treatment of the cells and flow cytometry analysis using a proaerolysin variant (FLAER). The mechanism of GPI anchor protein deficiency was studied by DNA gene sequencing, a cell-free assay to investigate the GPI anchor biosynthetic pathway, microarray analysis, and quantitative real-time polymerase chain reaction.

resultsBurkitt lymphoma cell lines harbor large populations of FLAER(neg) cells, which are resistant to proaerolysin. In all three cell lines, silencing of a gene involved in an early step in GPI-anchor biosynthesis was responsible for the lack of GPI-anchored proteins on the cell surface. Quantitative polymerase chain reaction and microarray analysis demonstrate that the level of mRNA for PIGL and PIGY is lower in the FLAER(neg) Ramos cells and that mRNA levels of PIGY are reduced in the Akata and Daudi cells. Hypermethylation of these genes was associated with the low levels of mRNA and treatment of the cells with 5-aza-2' deoxycytidine restored cell surface GPI-anchored proteins to the FLAER(neg) cells.

conclusionGPI-anchored protein deficiency in Burkitt lymphoma cells is not due to a genetic mutation (e.g., PIGA); rather, the lack of GPI-anchored proteins results from transcriptional silencing of PIGL and PIGY.

Indexed as

Gene SilencingBurkitt LymphomaCell Line, TumorFlow CytometryGlycosylphosphatidylinositolsHematopoietic SystemHumansImmunohistochemistryReverse Transcriptase Polymerase Chain ReactionRNA, MessengerGlycosylphosphatidylinositolsRNA, Messenger

Identifiers

PMID19302917
PMCPMC2763298
OpenAlexW1974237386

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.